---
schema_version: "secwatch.filing_event.v1"
accession: "0001558370-22-012967"
form_type: "8-K"
ticker: "AZTA"
cik: "0000933974"
company_name: "Azenta, Inc."
filed_at: "2022-08-10T23:59:59+00:00"
generated_at: "2026-06-24T01:42:30.488190+00:00"
event_type: "m_and_a"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Azenta to acquire B Medical Systems for €410M cash plus €50M earnout

## Summary
- Cash purchase price €410M; up to €50M additional contingent consideration based on performance milestones.
- B Medical generated ~€109M revenue in last twelve months ending June 30, 2022.
- Transaction expected to close in October 2022, subject to customary conditions.
- Acquisition expected to be accretive to non-GAAP earnings in FY2023 and GAAP earnings in FY2024.
- B Medical CEO Luc Provost and Deputy CEO Jesal Doshi expected to remain with Azenta.

## SEC filing metadata
- accession: 0001558370-22-012967
- form_type: 8-K
- ticker: AZTA
- cik: 0000933974
- company_name: Azenta, Inc.
- filed_at: 2022-08-10T23:59:59+00:00
- event_type: m_and_a
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 1.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/933974/000155837022012967/0001558370-22-012967-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/933974/000155837022012967/azta-20220808x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001558370-22-012967
- JSON: https://secwatch.observer/filing/0001558370-22-012967.json
- Plain text: https://secwatch.observer/filing/0001558370-22-012967.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.